Fredun Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 213.05 | 160.92 | 145.29 |
| Operating Expense | 183.92 | 134.59 | 122.96 |
| Net Profit | 11.07 | 10.48 | 9.73 |
| Net Profit Margin | 5.20% | 6.51% | 6.70% |
| Earning Per Share | 20.22 | 22.19 | 20.61 |
| EBIDTA | 29.14 | 26.33 | 22.33 |
| Effective Tax Rate | 1.61% | 13.36% | 14.64% |
Particulars
Mar 2026
Revenue213.05
Operating Expense183.92
Net Profit11.07
Net Profit Margin5.20
Earning Per Share20.22
EBIDTA29.14
Effective Tax Rate1.61
